ライフサイエンスコーパス: will hopefully

1 The use of mice will hopefully accelerate progress towards useful regene

2 subspeciality expertise in prostate MRI and will hopefully accelerate the clinical translation of AI

3 enal of drugs, biologics and strategies that will hopefully address these needs.

4 bitors when measuring TE or mRNA levels, and will hopefully aid in future experimental design as well

5 l in predicting severity of illness but also will hopefully allow for identification of the disease p

6 Better understanding of these mechanisms will hopefully allow us to improve treatment strategies

7 sent a random sample from India, our results will hopefully assist in the design of future studies th

8 ssion of axonal dysfunction more broadly and will hopefully assist in the development of successful i

9 lating biomarkers or therapeutic modalities, will hopefully be able to provide a strong basis for fut

10 ng disease or genetic context are needed and will hopefully be addressed by future work in this field

11 ms, be they pharmacological or psychosocial, will hopefully be developed.

12 g initiation, pausing, and elongation, which will hopefully be of interest to both O-GlcNAc and RNAPI

13 ferent agents in synergistic strategies that will hopefully be successful in stopping the growth and

14 e investment in public health infrastructure will hopefully be sustained in the United States so that

15 s compilation of industry experience in FBDD will hopefully be useful for those pursuing FBDD in acad

16 o highlight recent, select developments that will hopefully benefit the new and seasoned scientist al

17 channel distribution should be possible and will hopefully bring safer and more-potent medicines in

18 ding of the pathophysiology of chronic pain, will hopefully bring the promise of new therapeutics tha

19 with chemotherapeutic regimens continues and will hopefully broaden our treatment strategy for patien

20 forms for the treatment of relapsed MCL, and will hopefully change the outcome for patients with this

21 Ultimately, these tracers will hopefully clarify the pathophysiological role of am

22 Future multidisciplinary curricular progress will hopefully continue to build upon this e-learning st

23 d characterization of predictive biomarkers, will hopefully continue to improve clinical outcomes, re

24 The emerging technologies will hopefully continue to promote this trend.

25 mitochondrial dysregulation in autoimmunity will hopefully contribute to accelerating the developmen

26 These findings will hopefully contribute to an exploration of the funct

27 e simplified CPR guidelines released in 2005 will hopefully contribute to improved bystander delivery

28 ly based harmonized definition of MHO, which will hopefully contribute to more comparable data in the

29 thophysiology of chronic itching conditions, will hopefully contribute to the development of new anti

30 Future research will hopefully define specific risk prediction tools and

31 Future studies will hopefully define the benefits and role of cancer su

32 The manuscript will hopefully dispel a number of misconceptions and pro

33 New insights will hopefully emerge once the first detailed lipoprotei

34 e most extensively researched and strategies will hopefully emerge to increase its activity and provi

35 This broad resource will hopefully enable the community to identify other ce

36 These data will hopefully encourage labs to perform the necessary v

37 llenging, but neglected area of rheumatology will hopefully entice them to explore these conditions w

38 This is a welcome change that will hopefully expand therapeutic option for patients af

39 These formalized consensus descriptions will hopefully facilitate ongoing and future research ef

40 This document provides a framework that will hopefully facilitate the clearest communication bet

41 The proposed criteria will hopefully facilitate the development of novel appro

42 ding of the pathogenesis of nephrolithiasis, will hopefully facilitate the future development of targ

43 -cell lung cancer (NSCLC) is progressing and will hopefully follow in the same footsteps as that of b

44 pproaches to modulate inflammatory pathways, will hopefully further expand our ability to understand

45 use of new drugs such as brentuximab vedotin will hopefully further increase the cure rates.

46 mechanism leading to the DGS/VCFS phenotype will hopefully further our understanding of cardiac deve

47 cular markers built into many ongoing trials will hopefully generate more insights in the near future

48 els of PD, and in clinical trial methodology will hopefully hasten the resolution of these problems.

49 Consideration of these issues now will hopefully help foster an informed approach to the c

50 coverage, these estimates of total incidence will hopefully help guide efforts to appropriately incre

51 These research priorities will hopefully help inform, encourage, and stimulate inn

52 f non-narcotic therapeutics, which, in turn, will hopefully help lessen misuse of opioid pain medicat

53 of data into the beginnings of a model that will hopefully help to guide research towards a full-sca

54 brosis provides new research directions that will hopefully help us better understand and address fib

55 ogress in the understanding of DC physiology will hopefully help us create the necessary vaccines to

56 roader understanding of the biology of MF/SS will hopefully identify more effective targeted therapie

57 n vitro and in vivo preclinical studies that will hopefully identify therapies that target the malign

58 rget other pathways involved in angiogenesis will hopefully improve on the results of current anti-VE

59 ose of stimulating high-impact research that will hopefully improve outcomes among people with COPD a

60 for the assessment of practice patterns that will hopefully improve physician decision making.

61 Advanced neuroimaging and liquid biopsy will hopefully improve response evaluation.

62 reatment of relapsed and refractory NHL, and will hopefully improve the clinical outcome for these pa

63 njury in a bio-psycho-socio-ecological model will hopefully improve understanding of the underlying c

64 Knowledge of the lipidic contribution will hopefully inspire development of novel synthetic bi

65 e attention of all relevant shareholders and will hopefully inspire future national and local guideli

66 These new insights will hopefully inspire future studies that harness both

67 s of climate change on migratory species and will hopefully inspire future work on rainfall and tropi

68 le for preclinical medicine, in general, and will hopefully instill greater confidence in the clinica

69 immune triggers of IBD in a genetic context will hopefully lead to a better understanding of the pat

70 pplying concepts learned in HIV therapeutics will hopefully lead to a prudent and cautious path in HC

71 stigators to dissect these features and that will hopefully lead to additional advances in the future

72 nd endpoints leading to multicenter studies, will hopefully lead to advancements in the prevention of

73 ecretion, delivery and function of effectors will hopefully lead to alternative control measures, whi

74 This knowledge will hopefully lead to better diagnosis and treatment an

75 of lung development and regeneration, which will hopefully lead to better insights into both congeni

76 s in the context of other signaling pathways will hopefully lead to biology based therapeutic strateg

77 ects in various models over the coming years will hopefully lead to establishment of this receptor as

78 on of LQTS patients and their family members will hopefully lead to improved gene-specific prognostic

79 ogy into uniformly adopted response criteria will hopefully lead to improved outcome for patients wit

80 m that uses these techniques is proposed and will hopefully lead to improved patient management.

81 ooms better predict conjunctivitis cases and will hopefully lead to improved prevention efforts that

82 g of the determinants of disease progression will hopefully lead to improved utilization of existing

83 emiology and pathophysiology of this disease will hopefully lead to improvement in patient outcomes.

84 anding of the pathophysiology of the bladder will hopefully lead to more effective and tolerated trea

85 These advances will hopefully lead to more effective therapies for spec

86 anding of afferent mechanisms in the bladder will hopefully lead to more effective treatments of lowe

87 isease mutations in the entire isoform space will hopefully lead to new biomarkers, therapeutic targe

88 pared to those due to infectious causes, and will hopefully lead to new therapies.

89 dissection of these molecular pathways that will hopefully lead to novel therapeutic options.

90 biogenesis cause specific clinical syndromes will hopefully lead to novel therapeutic strategies for

91 ithelial goblet cell abnormalities in asthma will hopefully lead to novel therapies for mucin hyperse

92 in pre-clinical or early clinical evaluation will hopefully lead to safe and effective disease-modify

93 Understanding its unique pathogenesis will hopefully lead to the development of better, more t

94 proved understanding of CMML pathophysiology will hopefully lead to the exploration of novel targets

95 er progression in inflammatory bowel disease will hopefully lead to the identification of useful prog

96 f interstitial cystitis is emerging and this will hopefully lead to the introduction of novel therapi

97 This review will hopefully look at the recent evidence in the field

98 These changes will hopefully make ape a useful software for the study

99 eptor tyrosine kinase FLT3, and its approval will hopefully mark the beginning of an era of targeted

100 lication of more advanced signal processing, will hopefully open new avenues of research leading to t

101 Characterizing this network will hopefully open the way to therapeutic approaches th

102 The insights within this review will hopefully pave the way for future evidence-based ge

103 These advances will hopefully pave the way for improving both the proph

104 garette smoke can damage airway function and will hopefully pave the way for the development of ratio

105 This will hopefully permit a better future for patients with

106 physics literature as "phenomenology"; they will, hopefully, play a significant role in future studi

107 ase course or in combination with each other will hopefully produce more durable responses with less

108 t population is exciting and much needed and will hopefully prompt further investigation into additio

109 in concert with other transcription factors will hopefully provide a better mechanistic understandin

110 This model will hopefully provide a useful framework for studying m

111 individual, the genetically modified T cells will hopefully provide durable killing of infected cells

112 Ongoing risk-adapted studies will hopefully provide evidence for clinical improvement

113 ated mechanosensation and signaling activity will hopefully provide important insights into the mecha

114 s the best validated of the new markers, and will hopefully provide insight into how to use this biom

115 abilisation of tumour volume with everolimus will hopefully provide long-term clinical benefit in pat

116 An integrative view of the different levels will hopefully provide much needed insight into understa

117 egarding epigenetic control mechanisms which will hopefully provide new advances in diagnostics and p

118 The accumulating data from these studies will hopefully provide new ideas for combating autoimmun

119 into the mechanism involved in this response will hopefully provide new insight into the pathogenesis

120 of melanocyte contributions to skin biology will hopefully provide new opportunities for the prevent

121 Thus, BiTE((R)) antibody constructs will hopefully provide new treatment options for patient

122 Ongoing high-throughput genetic projects will hopefully provide novel insight into the biological

123 These data will hopefully provide the impetus for development of no

124 This will hopefully provide the necessary impetus to change t

125 h bevacizumab and paclitaxel, is planned and will hopefully provide us with new directions on how to

126 This work will hopefully provide useful guidelines for the fMRIpre

127 lerosis is not only clinically relevant, but will hopefully provide valuable insights into the mediat

128 elevant targets in neoplastic mast cells and will hopefully receive recognition by health authorities

129 hts and candidate therapeutics to the clinic will hopefully reduce the morbidity and mortality caused

130 to develop novel therapeutic strategies that will hopefully result in better treatment outcomes.

131 opism of liver metastasis from breast cancer will hopefully result in improved targeted therapies to

132 rocesses underlying kidney injury and repair will hopefully result in the design of more targeted the

133 ration in the pharmaceutical industry, which will hopefully result in the development of improved bon

134 Further studies will hopefully reveal the pathogenic role of these metab

135 tero continue to improve, future generations will hopefully see a reduction in both prenatal and neon

136 mmes in non-model organisms, the next decade will hopefully see these phylogenetic findings integrate

137 datasets or questions, the concepts and code will hopefully serve as a foundation for future analyses

138 The technique will hopefully serve as a guide for the further analysis

139 This review will hopefully serve as a guide for the unique strategie

140 ularly encapsulated organism infections, and will hopefully serve as guidance for nephrologists utili

141 This study will hopefully serve to complement previously reported D

142 and controversies and ongoing trials, which will hopefully shed light in these areas.

143 standardized and the next stages of research will hopefully shed light on how to maximize the efficac

144 These studies will hopefully shed light on the relative impact of thes

145 acids with the capacity for phloem transport will hopefully shed new light on the regulation of phloe

146 applications of leptin continue to grow and will hopefully soon be used therapeutically.

147 riving disease progression and heterogeneity will hopefully soon transform the care for patients with

148 This summary will hopefully spur further quality content and engageme

149 cancer immunosurveillance and immunoediting will hopefully stimulate development of more effective i

150 risk into clinical trials using novel agents will hopefully streamline head and neck cancer chemoprev

151 epithelial immune and inflammatory responses will hopefully suggest new strategies for therapeutic in

152 These new technologies will hopefully support the use of GEMs in preclinical tr

153 nderstanding of PTEN function and regulation will hopefully translate into improved prognosis and tre

154 variety of infection and inflammation models will hopefully translate to new therapies.

155 tionary adaptations to become predatory, and will hopefully ultimately illuminate how the predatory p

156 udies should yield important new data, which will hopefully ultimately result in improved outcomes.

157 This review will hopefully will provide useful material for future s